CN110354060A - 一种冻干式面膜及其生产工艺 - Google Patents
一种冻干式面膜及其生产工艺 Download PDFInfo
- Publication number
- CN110354060A CN110354060A CN201910713627.4A CN201910713627A CN110354060A CN 110354060 A CN110354060 A CN 110354060A CN 201910713627 A CN201910713627 A CN 201910713627A CN 110354060 A CN110354060 A CN 110354060A
- Authority
- CN
- China
- Prior art keywords
- mask
- extract
- facial mask
- ceramide
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 74
- 238000004519 manufacturing process Methods 0.000 title abstract description 13
- 238000004108 freeze drying Methods 0.000 title abstract description 11
- 238000005516 engineering process Methods 0.000 title abstract description 3
- 239000000463 material Substances 0.000 claims abstract description 50
- 239000004744 fabric Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000005507 spraying Methods 0.000 claims abstract description 15
- 239000003755 preservative agent Substances 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 106
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 32
- 229940106189 ceramide Drugs 0.000 claims description 25
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 23
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 23
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 23
- 239000011248 coating agent Substances 0.000 claims description 23
- 238000000576 coating method Methods 0.000 claims description 23
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 23
- 150000004676 glycans Chemical class 0.000 claims description 21
- 229920001282 polysaccharide Polymers 0.000 claims description 21
- 239000005017 polysaccharide Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- 102000008186 Collagen Human genes 0.000 claims description 18
- 108010035532 Collagen Proteins 0.000 claims description 18
- 241001530056 Athelia rolfsii Species 0.000 claims description 17
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 17
- 229930195725 Mannitol Natural products 0.000 claims description 17
- 229960003237 betaine Drugs 0.000 claims description 17
- 239000000594 mannitol Substances 0.000 claims description 17
- 235000010355 mannitol Nutrition 0.000 claims description 17
- 229920000223 polyglycerol Polymers 0.000 claims description 17
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 16
- 229920002498 Beta-glucan Polymers 0.000 claims description 16
- 241000588986 Alcaligenes Species 0.000 claims description 14
- 229920001661 Chitosan Polymers 0.000 claims description 14
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 claims description 14
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 14
- 229940095137 ceramide 6 ii Drugs 0.000 claims description 14
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 13
- 102000002322 Egg Proteins Human genes 0.000 claims description 13
- 108010000912 Egg Proteins Proteins 0.000 claims description 13
- 235000014103 egg white Nutrition 0.000 claims description 13
- 210000000969 egg white Anatomy 0.000 claims description 13
- 229940059958 centella asiatica extract Drugs 0.000 claims description 11
- 241000242583 Scyphozoa Species 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 10
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 9
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 claims description 9
- ZGBFGAHZKZQSLG-UMCOJZBLSA-N [30-oxo-30-[[(e,2s,3r,6r)-1,3,6-trihydroxyoctadec-4-en-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCC[C@@H](O)\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC ZGBFGAHZKZQSLG-UMCOJZBLSA-N 0.000 claims description 9
- 229940048864 ceramide 1 Drugs 0.000 claims description 9
- 229940044176 ceramide 3 Drugs 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 239000004745 nonwoven fabric Substances 0.000 claims description 9
- -1 silk Substances 0.000 claims description 9
- 229940099417 ceramide 2 Drugs 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 8
- 239000003292 glue Substances 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 150000005846 sugar alcohols Chemical class 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 235000010678 Paulownia tomentosa Nutrition 0.000 claims description 2
- 240000002834 Paulownia tomentosa Species 0.000 claims description 2
- 241001506047 Tremella Species 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 150000001783 ceramides Chemical class 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 26
- 239000000047 product Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 239000011265 semifinished product Substances 0.000 abstract description 13
- 239000011149 active material Substances 0.000 abstract description 11
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 8
- 230000002335 preservative effect Effects 0.000 abstract description 6
- 230000001954 sterilising effect Effects 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 238000004945 emulsification Methods 0.000 abstract 3
- 230000002155 anti-virotic effect Effects 0.000 abstract 2
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 238000004064 recycling Methods 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 229920002385 Sodium hyaluronate Polymers 0.000 description 12
- 229940010747 sodium hyaluronate Drugs 0.000 description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 12
- 241001071795 Gentiana Species 0.000 description 9
- 241000212948 Cnidium Species 0.000 description 8
- 241000049464 Artemisia apiacea Species 0.000 description 7
- 235000011570 Artemisia caruifolia var apiacea Nutrition 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 235000020725 licorice root extract Nutrition 0.000 description 7
- 241000246044 Sophora flavescens Species 0.000 description 6
- 229940045110 chitosan Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 5
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 5
- 229940051810 licorice root extract Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000011068 loading method Methods 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 235000001405 Artemisia annua Nutrition 0.000 description 2
- 240000000011 Artemisia annua Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 2
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 229940068517 fruit extracts Drugs 0.000 description 2
- 239000003779 heat-resistant material Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- GJLNWLVPAHNBQN-UHFFFAOYSA-N phenyl 4-hydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OC1=CC=CC=C1 GJLNWLVPAHNBQN-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010023 transfer printing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种冻干式面膜及其生产工艺,其生产工艺步骤如下:(1)调配原料,将面膜原料中耐高温材料进行乳化搅拌加热,并储存于已消菌杀毒的容器中保温;(2)将乳化搅拌的耐高温材料在烘干隧道内进行循环多次,然后涂在面膜布上,制成半成品;(3)乳化搅拌面膜活性材料,并存储于消菌杀毒后的容器中;(4)将乳化搅拌的面膜活性材料循环多次,喷射到上述半成品上;(5)将喷涂完成的半成品进行速冻,抽湿,并进行封装,制成成品;采用上述方法制成的面膜,活性成份留存时间更久更多,功效好,面膜整体重量轻,便于携带与运输,面膜中无防腐剂,因此不会因为防腐剂引起的皮肤过敏及损害,使用时用清水浸泡即可。
Description
技术领域
本发明涉及一种面膜及其生产工艺,具体涉及一种冻干式面膜及其生产工艺,属于面膜生产技术领域。
背景技术
面膜是一种很好的护肤产品,深受广大消费者的喜欢,现有面膜均为湿式,拆开包装即可使用。但因其为湿式,一方面为了防止细菌的滋生,需要添加防腐剂,一方面存在携带不方便的问题,其次其重量相对比较重,运输成本高;传统的面膜,由于液、膏体中由于含有大量的水份,为了保持面膜的有效性与保存时间,故产品必须添加防腐剂成份,如:尼泊金酯(如甲酯、乙酯、内酯等),以保证液、膏体不变质。众所周知,防腐剂对人体是有害的,经常使用会伤害到皮肤组织,2004年Darbre的研究报道在乳腺癌组织中检测到5种常见尼泊金酯的成分引起国际化妆品行业对尼泊金酯类的安全性大讨论。
欧洲消费者安全科学委员会(Scientific committee on consumer safety,简称SCCS)分别在2010年,2011年和2013年对尼泊金酯类物质的安全性进行评估,产品使用剂量也在不断调整。2013年5月,SCCS/1514/13对尼泊金酯类物质的使用量建议“尼泊金甲酯和尼泊金乙酯在法规最大使用剂量下是安全的,其中尼泊金甲酯:0.4%,尼泊金乙酯:0.4%;尼泊金丙酯和丁酯在单独或联合使用时剂量<0.19%(以酯计)是安全的;对羟基异丙脂、对羟基异丁酯以及苯基对羟基苯甲酸酯等的研究数据不足,安全性不明。”欧盟在其1223/2009法规中采纳SCCS/1514/13中对尼泊金甲酯和乙酯的建议,同时建议将尼泊金丙酯和丁酯在单独或联合使用时最高剂量为<0.14%(以酸计),并规定在3岁以下儿童的留存型尿布产品中禁止使用尼泊金丙酯和丁酯。美国化妆品成分审查委员会(Cosmetic IngredientReview,简称CIR)在近5年内都没有关于尼泊金酯类安全性的评估,最近的安全性评估更新在2008年,结论是在最高限量(单独使用0.4%,总量不超过0.8%)下可以安全使用。如欧盟专家组认为尼泊金酯由于最近的研究证明其对实验大鼠具有某些生殖的影响,所以防腐剂的长期使用对人体的影响是不利的。
由于防腐剂的影响,已经开发出不含有防腐剂的面膜。
CN109700697A公开了一种采用冷冻干燥法生产的无水面膜,其制备方法为将面膜液涂抹在无纺布等面膜载体表面形成面膜浆层后采用冻干的方法干燥制备而成,由于采用恒温抽湿的干燥技术,该面膜不含有水分,解决了防腐的问题。但是该面膜中由于含有卡波姆、琼脂等增稠剂成分,其面膜液粘度较高,采用涂覆在无纺布表面的工艺导致面膜制备时间较长,面膜液容量较小,面膜厚度较大。
CN109394552A公开了一种冻干面膜,其制备方法为将面膜巾至于容器中注入面膜液后半密封充分混合,并将其冷冻干燥,使得其面膜液呈现为冻干粉的形式。使用时配套高温灭菌的去离子水。具信,采用该方法制备的面膜为干性面膜,易于保存并降低微生物感染的机率,进而免除了防腐剂的使用。该方法制备的面膜液中不含有增稠剂成分,面膜液可以很容易的浸润到无纺布中,但是由于不含有增稠剂蹭饭,使用时,容易造成面膜液滴落的现象。
还开发出冻干方法制备的面膜技术。
CN109674692A公开了一种生物纤维面膜,包括生物纤维膜布和精华液,其制备方法为将膜布浸泡在精华液中2-4h后冻干获得。该方法采用生物纤维膜布成本相对较高,并且面膜液同样含有增稠剂成分,导致面膜液浸泡时间较长。CN109464355A公开了面膜份的制备方法,其包括将植物提取物提取后冻干成面膜粉,使用时加入水、蜂蜜水或者柠檬汁等。该面膜不使用无纺布载体,使用时需要制成可涂覆的膏体,使用不方便。
CN101889958A公开了一种冻干组合物,其含有聚丙烯酸盐的聚合物和天然聚合物以及活性成分或辅助物质,该冻干组合物与水溶液套组配置的组合物可以作为化妆面膜,但是由于其使用大量聚合物直接成膜,其透气性较差,并且具有较强的粘感。
已有的采用冻干工艺制备的面膜,仍然存在制备时间较长、面膜的厚度较大,粘附不均匀,使用时无法充分使用的缺点,由此造成生产成本和消费成本的增加。
因此仍然需要寻找一种合适的面膜的制备方法。更进一步的提高面膜的保存时间,重量轻,方便携带与使用。不添加防腐剂,减少对人体的负面影响,又能很好的保存面膜的有效活性。
发明内容
发明人通过研究发现,通过将面膜液中耐高温材料预涂覆于无纺布等面膜材质,然后将不含有防腐剂的面膜液浸润到预处理面膜材质通过冻干的方法能够解决上述问题。
因此本发明的目的在于提供一种面膜组合物,其由面膜液与预处理的面膜基材通过冻干的方法制备而成。
具体的,所述预处理面膜基材由包括聚甘油类,甜菜碱,糖醇和微生物胶的耐高温材料和面膜材质组成。
所述聚甘油类选自:聚甘油-2,聚甘油-3,麦芽糖,聚甘油-4,聚甘油-6,聚甘油-10,聚甘油-20,聚甘油-40中的一种或两种以上的组合。优选聚甘油-10。
所述多元糖醇选自:木糖醇,葡萄糖醇,山梨糖醇,甘露醇中的一种或两种以上的组合。优选甘露醇。
所述微生物胶选自:黄原胶、小核菌胶中的一种或其组合。优选小核菌胶。更优选水解小核菌胶。
所述面膜材质包括全棉、混纺、蚕丝、无纺布中的一种或多种;
所述面膜组合物含有:
1)多糖类物质,其选自产碱杆菌多糖类、羧甲基脱乙酰壳多糖、β-葡聚糖中的一种或两种以上的组合;
2)神经酰胺类,其选自经酰胺1、神经酰胺2、神经酰胺3、神经酰胺4 、神经酰胺6 II中的一种或两种以上的组合;
3)高分子保湿成分,其选自透明质酸、银耳多糖等;
4)胶原蛋白,特别是水解胶原蛋白;
5)任选的提取物,例如蛋清提取物、小雨燕窝提取物、水母提取物、积雪草提取物等。
所述组合物不含有防腐剂。
根据本发明的目的,本发明还涉及冻干面膜的制备方法,其包括:
步骤1:面膜材质预处理:加热混合耐高温材料;将混合均匀的耐高温材料在烘干隧道内进行循环多次涂于面膜材质,制成预处理面膜基材;设备功率:60KW,电源规格三相380V50Hz-60Hz,外型4800*1800*850,膜布经过料槽用双辊筒转印方式均匀连续上料,然后经过烘干隧道循环回来料槽不断上料,保证同一地方的布至少上料三次,上料完成后就在隧道循环烘干大概100分钟至完全干燥;双辊筒可以通过调间隙的大小和辊筒的速度来调节上料的多少和均匀度,然后上了料的膜布接着通过上下都布有发热管并带有负压的半封闭隧道,来回上料来回干燥 ;
步骤2:面膜液的制备:将多糖类物质,神经酰胺类,高分子保湿成分,任选的活性成分搅拌混合均匀;
步骤3:将步骤2制备的面膜液循环多次喷射涂抹在步骤1制备的与处理面膜材质上;在完成步骤1后的面膜卷材在经过冷冻隧道前先经过一个密封的高压雾化喷射短隧道,这段物料就是这里循环喷涂完成,送料气缸这32-100,压缩空气压强0.6-0.8MPa;雾化喷射上料隧道,上的料的粘度和水差不多很容易雾化,该段的上料均匀效果取决于雾化头的分布均匀度、雾化头的压力大小、雾化的时间和膜布输送带速度的配合;
步骤4:将喷涂完成的面膜进行速冻,抽湿,并进行封装;
其中,
所述烘干隧道空间内环境温度为80℃~120℃之间,干燥时间100~120分钟;设备功率:60KW,电源规格三相380V 50Hz-60Hz,外型4800*1800*850,膜布经过料槽用双辊筒转印方式均匀连续上料,然后经过烘干隧道循环回来料槽不断上料,保证同一地方的布至少上料三次,上料完成后就在隧道循环烘干大概100分钟至完全干燥;双辊筒可以通过调间隙的大小和辊筒的速度来调节上料的多少和均匀度,然后上了料的膜布接着通过上下都布有发热管并带有负压的半封闭隧道,来回上料来回干燥;
所述面膜液喷射的温度为-10℃~-5℃,并抽湿;
所述面膜液的涂覆,利用面膜涂层机将所述面膜液涂抹在所述预处理面膜基材上;
所述速冻温度为不高于-40℃;
根据本发明的优选方式,
所述预处理耐热材料中,基于预处理面膜材质的耐热材料总重量份,其包含:
1-10份聚甘油类,优选2-4.5份,更优选4份;
1-5份甜菜碱,优选2-4.5份,更优选2份;
1-3份糖醇类,优选2.5-3份,更优选2.5份;
0.1-0.5份微生物胶,优选0.3-0.4份,更优选0.4份;
以及去离子水余量。
所述面膜液中,基于面膜液的总重量份,其包含:
1)多糖类物质0.1-1%份,优选0.2-0.5份,更优选0.3份;
2)神经酰胺类0.001-0.5份,优选0.005-0.1份,更优选0.05份;
3)高分子保湿成分0.05-0.5份,优选0.1-0.2份,更优选0.15份;
4)胶原蛋白0.01-2份,优选0.05-1份,更优选0.5份;
5)提取物0.1-10份,优选0.5-5份,更优选3份;
以及去离子水余量。
更优选的一个技术方案中,
所述耐热预处理材料中,基于耐热预处理材料总重量份,包含:
4份聚甘油,2份甜菜碱,2.5份甘露糖醇,0.4份胶水解小核菌,余量为去离子水;
所述面膜液,基于面膜液总种类重量份,其包含:0.1份羧甲基脱乙酰壳多糖,0.25份产碱杆菌多糖类,0.005份β-葡聚糖,0.001份神经酰胺1,0.001份神经酰胺,0.001份神经酰胺3,0.001份神经酰胺4,0.001份神经酰胺6II,0.1份透明质酸钠,0.05份水解胶原蛋白,0.05份活性提取物,0.05份积雪草提取物,0.05份提取物混合物,以及去离子水余量;
其中,所述活性提取物包括小雨燕窝提取物、水母提取物中的一种;所述提取物混合物原料含量配比包括丙二醇50份,水37份,苦参提取物1份,甘草根提取物5份,龙胆根提取物5份,蛇床果提取物1份,青蒿提取物1份;
进一步的,本发明还涉及一种套装,其包括冻干面膜和独立包装的去离子水;
进一步的,本发明还涉及面膜的使用方法,其包括将冻干面膜用独立包装的去离子水浸泡后适用于面部。
根据本发明制备的冻干式面膜制品:含水量低,既不会丢失原有的营养液成分,也不会给任何微生物细菌提供生长繁殖的环境。因此,在无需添加防腐剂情况下,既保证了面膜的防腐防菌的效果,也不会给人体皮肤造成任何不良的影响,同时保证了面膜的化妆效果,同时由于重量请,其携带更加方便。
附图说明
图1面膜生产工艺的流程图。
具体实施方式
下面将结合实施例对本发明的技术方案进行清楚完整的描述,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
下面的示例仅出于说明目的且不用于以任何方式不恰当地限制本发明的范围。
1、预处理组合物的制备:将聚甘油10 4份,甜菜碱2份,甘露糖醇2.5份,水解小核菌胶0.4份搅拌加热到80℃,得到混合原料,保温;
2、面膜液的制备:将产碱杆菌多糖类0.25份,蛋清提取物0.01份,羧甲基脱乙酰壳多糖0.1份,透明质酸钠0.1份,神经酰胺1 0.001份,神经酰胺2 0.001份,神经酰胺3 0.001份,神经酰胺4 0.001份,神经酰胺6 II 0.001份,活性提取物0.05份,水解胶原0.05份,积雪草提取物0.05份,提取物混合物0.05份,β-葡聚糖0.005份;活性提取物为小雨燕窝提取物、水母提取物中的一种;制备面膜液时,用到去离子水5到10份在乳化锅中搅拌混合均匀,得面膜液。并中45℃左右保温;
3、将耐高温预处理材料在烘干隧道内中80-120℃的条件下进行循环多次涂在面膜布,面膜布的材料是30G的桐胺纤维复合材料,并干燥100分钟,制成预处理面膜基材;面膜布宽1.5米,单位面积喷量为干燥后5G/平方,一平方上料的膜布重量减去没上料的膜布的重量,就可以得出来上料的情况;
4、在-10℃,开启抽湿的条件下,将面膜液循环多次喷射涂抹在所述预处理面膜基材上;一平方的面膜基材,喷10-15G的量,手的触感和一平方上料的膜布重量减去没上料的膜布的重量,就可以得出来上料的情况;
5、在-40℃,抽湿的条件下,将喷涂完成的面膜进行速冻,抽湿,并进行封装成制冻干型面膜。
实施例2
该冻干式面膜生产工艺包括以下步骤:
S1、调配原料,将面膜原料中耐高温材料进行乳化搅拌,并储存于已消菌杀毒的容器中;
具体的,调配水母面膜的原料包括水、聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,活性提取物,蛋清提取物,羧甲基脱乙酰壳多糖,丙二醇,透明质酸钠,神经酰胺 1,神经酰胺2,神经酰胺 3,神经酰胺 4,神经酰胺 6 II,水母提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;
具体的,调配燕窝面膜的原料包括水,聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,蛋清提取物,羧甲基脱乙酰壳多糖,丙二醇,透明质酸钠,神经酰胺1,神经酰胺2,神经酰胺3,神经酰胺4,神经酰胺6 II,小雨燕窝提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;其中,调配的原料均为送检合格的原料;
举例来说,各原料重量配比如下:水85份,聚甘油10 10份,甜菜碱4.5份,甘露糖醇3份,水解小核菌胶0.45份,产碱杆菌多糖类0.3份,蛋清提取物0.5份,羧甲基脱乙酰壳多糖2份,透明质酸钠2.0份,神经酰胺1 0.1份,神经酰胺2 0.1份,神经酰胺3 0.1份,神经酰胺4 0.1份,神经酰胺6 II 0.1份,活性提取物2份,水解胶原2份,积雪草提取物0.15份,提取物混合物3份,β-葡聚糖1份;活性提取物为小雨燕窝提取物、水母提取物中的一种;
具体的,面膜布材质为全棉、混纺、蚕丝、无纺布等中的一种或多种;
具体的,对耐高温材料聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶等一种或多种材料进行乳化搅拌加热到80℃,得到混合原料,混合在已杀菌消毒的容器中保温30分钟;
S2、将乳化搅拌的耐高温材料在烘干隧道内进行循环多次涂在面膜布,制成半成品;
其中,烘干隧道空间内环境温度为120℃,干燥时间120分钟,生产过程中采用了高温杀菌工艺,干燥后的半成品面膜的含水量低于百分之三;
S3、乳化搅拌面膜活性材料,并存储于消菌杀毒后的容器中;
其中,面膜活性材料包括活性提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;
具体的,搅拌温度为45℃;
S4、将乳化搅拌的面膜活性材料循环多次喷射涂抹在所述半成品上;
具体的,喷射的环境处于-5℃,所述喷射还包括利用面膜涂层机想所述面膜活性材料涂抹在所述半成品上,并进行抽湿;
S5、将喷涂完成的半成品进行速冻,抽湿,并进行封装成制成品;
具体的,将喷涂完成的半成品进行速冻,抽湿,并进行封装包括,速冻的环境温度为-40℃;
其中,所述面膜制成品使用时用清水浸泡后即可使用;
具体的,一种冻干式面膜冻干后制成品原料成分包括聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,蛋清提取物,羧甲基脱乙酰壳多糖,透明质酸钠,神经酰胺1,神经酰胺2,神经酰胺 3,神经酰胺 4,神经酰胺 6 II,小雨燕窝提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种,通过消毒杀菌,对皮肤保湿以及皮肤调理有很大的功效,增强细胞组织活性,从而使皮肤更加滋润,达到美容的效果;其中:
制成品原料含量如下:聚甘油10 43份,甜菜碱28份,甘露糖醇19份,水解小核菌胶3.0份,产碱杆菌多糖类2份,蛋清提取物1.5份,羧甲基脱乙酰壳多糖2份,透明质酸钠1份,神经酰胺1 0.1份,神经酰胺2 0.1份,神经酰胺3 0.1份,神经酰胺4 0.1份,神经酰胺6 II 0.1份,活性提取物1.5份,水解胶原1.5份,积雪草提取物1份,提取物混合物4.0份,β-葡聚糖0.05份;其中,所述提取物混合物中苦参提取物0.8份,甘草根提取物0.8份,龙胆根提取物0.8份,蛇床果提取物0.8份,青蒿提取物0.8份。
实施例3
该冻干式面膜生产工艺包括以下步骤:
S1、调配原料,将面膜原料中耐高温材料进行乳化搅拌,并储存于已消菌杀毒的容器中;
具体的,调配水母面膜的原料包括水、聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,活性提取物,蛋清提取物,羧甲基脱乙酰壳多糖,丙二醇,透明质酸钠,神经酰胺 1,神经酰胺2,神经酰胺 3,神经酰胺 4,神经酰胺 6 II,水母提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;
具体的,调配燕窝面膜的原料包括水,聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,蛋清提取物,羧甲基脱乙酰壳多糖,丙二醇,透明质酸钠,神经酰胺1,神经酰胺2,神经酰胺3,神经酰胺4,神经酰胺6 II,小雨燕窝提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;其中,调配的原料均为送检合格的原料;
举例来说,各原料重量配比如下:水82份,聚甘油10 7份,甜菜碱3份,甘露糖醇2.8份,水解小核菌胶0.42份,产碱杆菌多糖类0.28份,蛋清提取物0.25份,羧甲基脱乙酰壳多糖1份,透明质酸钠1份,神经酰胺1 0.05份,神经酰胺2 0.05份,神经酰胺3 0.05份,神经酰胺40.05份,神经酰胺6 II 0.05份,活性提取物1.2份,水解胶原1.0份,积雪草提取物0.1份,提取物混合物1.5份,β-葡聚糖0.5份。活性提取物为小雨燕窝提取物、水母提取物中的一种;
具体的,面膜布材质为全棉、混纺、蚕丝、无纺布等中的一种或多种;
具体的,对耐高温材料聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶等一种或多种材料进行乳化搅拌加热到80℃,得到混合原料,混合在已杀菌消毒的容器中保温30分钟;
S2、将乳化搅拌的耐高温材料在烘干隧道内进行循环多次涂在面膜布,制成半成品;
其中,烘干隧道空间内环境温度为140℃,干燥时间120分钟,生产过程中采用了高温杀菌工艺,干燥后的半成品面膜的含水量低于百分之三;
S3、乳化搅拌面膜活性材料,并存储于消菌杀毒后的容器中;
其中,面膜活性材料包括活性提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种;
具体的,搅拌温度为45℃;
S4、将乳化搅拌的面膜活性材料循环多次喷射涂抹在所述半成品上;
具体的,喷射的环境处于-8℃,所述喷射还包括利用面膜涂层机想所述面膜活性材料涂抹在所述半成品上,并进行抽湿;
S5、将喷涂完成的半成品进行速冻,抽湿,并进行封装成制成品;
具体的,将喷涂完成的半成品进行速冻,抽湿,并进行封装包括,速冻的环境温度为-40℃;
其中,所述面膜制成品使用时用清水浸泡后即可使用;
具体的,一种冻干式面膜冻干后制成品原料成分包括聚甘油10,甜菜碱,甘露糖醇,水解小核菌胶,产碱杆菌多糖类,蛋清提取物,羧甲基脱乙酰壳多糖,透明质酸钠,神经酰胺1,神经酰胺2,神经酰胺 3,神经酰胺 4,神经酰胺 6 II,小雨燕窝提取物,水解胶原,积雪草提取物,苦参提取物,甘草根提取物,龙胆根提取物,蛇床果提取物,青蒿提取物,β-葡聚糖的一种或多种,通过消毒杀菌,对皮肤保湿以及皮肤调理有很大的功效,增强细胞组织活性,从而使皮肤更加滋润,达到美容的效果;其中:
制成品原料含量如下:聚甘油10 42份,甜菜碱26份,甘露糖醇17份,水解小核菌胶2.5份,产碱杆菌多糖类1.8份,蛋清提取物1.2份,羧甲基脱乙酰壳多糖1.8份,透明质酸钠0.6份,神经酰胺1 0.05份,神经酰胺2 0.05份,神经酰胺3 0.05份,神经酰胺4 0.05份,神经酰胺6 II 0.05份,活性提取物1.0份,水解胶原1.0份,积雪草提取物0.6份,提取物混合物3.5份,β-葡聚糖0.05份;其中,所述提取物混合物中苦参提取物0.5份,甘草根提取物0.5份,龙胆根提取物0.5份,蛇床果提取物0.5份,青蒿提取物0.5份。
Claims (3)
1.一种冻干式面膜,其特征在于:其包含面膜液与预处理的面膜基材;
所述预处理面膜基材由包括聚甘油类,甜菜碱,糖醇和微生物胶的耐高温材料和面膜材质组成;
所述聚甘油类选自:聚甘油-2,聚甘油-3,麦芽糖,聚甘油-4,聚甘油-6,聚甘油-10,聚甘油-20,聚甘油-40中的一种或两种以上的组合;
所述多元糖醇选自:木糖醇,葡萄糖醇,山梨糖醇,甘露醇中的一种或两种以上的组合;
所述微生物胶选自:黄原胶、小核菌胶中的一种或其组合;
所述面膜材质包括全棉、混纺、蚕丝、无纺布、桐胺纤维复合材料中的一种或多种;
所述面膜组合物含有:
1)多糖类物质,其选自产碱杆菌多糖类、羧甲基脱乙酰壳多糖、β-葡聚糖中的一种或两种以上的组合;
2)神经酰胺类,其选自经酰胺1、神经酰胺2、神经酰胺3、神经酰胺4 、神经酰胺6 II中的一种或两种以上的组合;
3)高分子保湿成分,其选自透明质酸、银耳多糖;
4)胶原蛋白;
5)任选的提取物,其选自蛋清提取物、小雨燕窝提取物、水母提取物、积雪草提取物中的一种或多种;
所述组合物不含有防腐剂。
2.根据权利要求1所述的一种冻干式面膜的制备方法,其包括如下步骤:
步骤1:面膜材质预处理:加热混合耐高温材料;将混合均匀的耐高温材料在烘干隧道内进行循环多次涂于面膜材质,制成预处理面膜基材;;
步骤2:面膜液的制备:将多糖类物质,神经酰胺类,高分子保湿成分,任选的提取物搅拌混合均匀;
步骤3:将步骤2制备的面膜液循环多次喷射涂抹在步骤1制备的预处理面膜材质上;
步骤4:将喷涂完成的面膜进行速冻,抽湿,并进行封装;
其中,所述烘干隧道空间内环境温度为80℃~120℃之间,干燥时间100~120分钟,所述面膜液喷射的温度为-10℃~-5℃;
所述面膜液的涂覆,利用面膜涂层机将所述面膜液涂抹在所述预处理面膜基材上;
所述速冻温度为不高于-40℃。
3.一种面膜套装,其包含根据权利要求1或2所述的一种冻干式面膜以及独立包装的去离子水。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910713627.4A CN110354060A (zh) | 2019-08-02 | 2019-08-02 | 一种冻干式面膜及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910713627.4A CN110354060A (zh) | 2019-08-02 | 2019-08-02 | 一种冻干式面膜及其生产工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110354060A true CN110354060A (zh) | 2019-10-22 |
Family
ID=68223135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910713627.4A Pending CN110354060A (zh) | 2019-08-02 | 2019-08-02 | 一种冻干式面膜及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110354060A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111743787A (zh) * | 2020-05-29 | 2020-10-09 | 泉后(广州)生物科技研究院有限公司 | 一种天然面膜及其制备方法 |
CN112006920A (zh) * | 2020-09-18 | 2020-12-01 | 广东柏文生物科技股份有限公司 | 一种冻干面膜的一段式动态冻干方法 |
CN112472612A (zh) * | 2020-08-11 | 2021-03-12 | 诺斯贝尔化妆品股份有限公司 | 一种冻干面膜的制备工艺及其产品 |
CN112641636A (zh) * | 2020-10-16 | 2021-04-13 | 诺斯贝尔化妆品股份有限公司 | 一种分区护理型面膜及其制备工艺 |
CN115363966A (zh) * | 2022-08-24 | 2022-11-22 | 诺斯贝尔化妆品股份有限公司 | 一种单面固态精华的冻干面膜制备工艺 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434720A (zh) * | 2014-11-11 | 2015-03-25 | 彤阳生技(杭州)有限公司 | 一种自发型温感面膜及其制备方法 |
CN204660326U (zh) * | 2015-02-12 | 2015-09-23 | 李和伟 | 一种新型的双室包装袋 |
CN107007477A (zh) * | 2016-01-27 | 2017-08-04 | 李和伟 | 一种多层改性法的改性膜布制备工艺及其产品 |
CN108295021A (zh) * | 2018-04-04 | 2018-07-20 | 广州赛莱拉干细胞科技股份有限公司 | 补水保湿组合物及其制备方法 |
CN108379208A (zh) * | 2018-05-08 | 2018-08-10 | 深圳市蔡府实业有限公司 | 一种燕窝焕肤面膜及其制备方法 |
-
2019
- 2019-08-02 CN CN201910713627.4A patent/CN110354060A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434720A (zh) * | 2014-11-11 | 2015-03-25 | 彤阳生技(杭州)有限公司 | 一种自发型温感面膜及其制备方法 |
CN204660326U (zh) * | 2015-02-12 | 2015-09-23 | 李和伟 | 一种新型的双室包装袋 |
CN107007477A (zh) * | 2016-01-27 | 2017-08-04 | 李和伟 | 一种多层改性法的改性膜布制备工艺及其产品 |
CN108295021A (zh) * | 2018-04-04 | 2018-07-20 | 广州赛莱拉干细胞科技股份有限公司 | 补水保湿组合物及其制备方法 |
CN108379208A (zh) * | 2018-05-08 | 2018-08-10 | 深圳市蔡府实业有限公司 | 一种燕窝焕肤面膜及其制备方法 |
Non-Patent Citations (1)
Title |
---|
广州市莱方信息科技有限公司: "oujiai欧极爱草本滋养保湿冻干面膜", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=201811081443033EKW8&NID=201811081443033EKW8》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111743787A (zh) * | 2020-05-29 | 2020-10-09 | 泉后(广州)生物科技研究院有限公司 | 一种天然面膜及其制备方法 |
CN111743787B (zh) * | 2020-05-29 | 2021-02-26 | 泉后(广州)生物科技研究院有限公司 | 一种天然面膜及其制备方法 |
CN112472612A (zh) * | 2020-08-11 | 2021-03-12 | 诺斯贝尔化妆品股份有限公司 | 一种冻干面膜的制备工艺及其产品 |
CN112006920A (zh) * | 2020-09-18 | 2020-12-01 | 广东柏文生物科技股份有限公司 | 一种冻干面膜的一段式动态冻干方法 |
CN112641636A (zh) * | 2020-10-16 | 2021-04-13 | 诺斯贝尔化妆品股份有限公司 | 一种分区护理型面膜及其制备工艺 |
CN115363966A (zh) * | 2022-08-24 | 2022-11-22 | 诺斯贝尔化妆品股份有限公司 | 一种单面固态精华的冻干面膜制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110354060A (zh) | 一种冻干式面膜及其生产工艺 | |
CN101889958B (zh) | 冻干组合物 | |
CN110464658B (zh) | 一种多效眼部冻干膜及蒸汽眼罩 | |
CN107519022B (zh) | 一种改性膜布制备工艺及其应用 | |
CN105147556A (zh) | 一种基质细胞活化因子精华素 | |
CN102697682B (zh) | 豆渣美白粉质面膜和面膜膏的制备方法 | |
CN104546560B (zh) | 一种含抗菌肽及表皮生长因子的干式膜及制备方法和应用 | |
CN107007477A (zh) | 一种多层改性法的改性膜布制备工艺及其产品 | |
US10849833B2 (en) | Manufacturing method of preservative-free facial mask and process equipment thereof | |
CN110025597A (zh) | 一种干巾及其加工方法和应用 | |
CN103505403A (zh) | 表皮生长因子复合物脂质体及其制备方法和应用 | |
CN113244137A (zh) | 一种冻干面膜精华、面膜及其制备方法 | |
CN107541528A (zh) | 发芽糙米的Saccharomyces veronae发酵液 | |
CN108542801A (zh) | 一种无防腐剂的护肤贴精华液 | |
CN106176256A (zh) | 一种面膜的制备方法 | |
CN110433116A (zh) | 一种含有天然成分抗炎祛痘面膜 | |
CN103479567A (zh) | 表皮生长因子复合脂质体及其制备方法和应用 | |
CN109908030A (zh) | 一种无水面膜的制作工艺 | |
CN1864753A (zh) | 贴剂 | |
CN106963690A (zh) | 一种超薄透气pe壳聚糖复合面膜及其制备方法 | |
CN111568781A (zh) | 一种护肤凝胶及其制备方法 | |
CN1061515C (zh) | 一种高效的葡萄保鲜纸制作方法 | |
CN110151662A (zh) | 一种植物精华素面部护理液及其制备方法 | |
CN115363966A (zh) | 一种单面固态精华的冻干面膜制备工艺 | |
KR20190119404A (ko) | 피부용 쌀눈시트마스크팩 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |